Donald L. Durden, MD, PhD, pediatric researcher at University of California, San Diego School of Medicine and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer. The agent, named SF1126, acts by inhibiting the part of the cancer cell engine that promotes tumor angiogenesis and growth.
A bioinformatics researcher at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, has been awarded a three-year National Institutes of Health (NIH) grant worth almost $1.4 million to make biological structures more widely available to scientists, educators, and students.
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person’s cancer, report University of California, San Diego School of Medicine researchers in the Journal of Oncology Practice.
UC San Diego has been named the 7th “Coolest School” by Sierra magazine, climbing 10 spots from last year in the publication’s annual ranking of America’s greenest colleges. The campus was recognized for its commitment to protecting the environment, reducing water use significantly, addressing climate issues and encouraging environmental responsibility.
A new study led by bioengineers at the University of California, San Diego defines the core set of genes and functions that a bacterial cell needs to sustain life. The research, which answers the fundamental question of what minimum set of functions bacterial cells require to survive, could lead to new cell engineering approaches for E. coli and other microorganisms, the researchers said.
This year's NASIT will feature lectures and workshops by professors from Stanford, USC, Carnegie Mellon and UC Irvine on a wide range of topics, including managing signal interference, optimizing data analysis and channel models for biological communications.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
